Newsletter | March 27, 2025

03.27.25 -- Challenges & Opportunities Of Outsourcing Biopharma Development

FEATURED EDITORIAL

Challenges And Opportunities Of Outsourcing Biopharma Development

Oversight, knowledge management, and operational/compliance risk make up the three key challenge classifications to consider when approaching a new outsourcing agreement.

Strengthening Shop-Floor QA From The Ground Up

Quality is created where and when manufacturing happens, not later through inspection. This approach integrates the QA function into daily production operations.

9 Reasons Why You Should Consider AI In Analytical Instrument Qualification

AI is about to completely change the analytical instrument qualification (AIQ) landscape in the pharma/biopharma and medical device industries.

INDUSTRY INSIGHTS

Enhance The Ease Of Use Batch Turnaround And Process Flexibility

Discover an effective strategy for improving product safety and process flexibility with a single-use TFF device that features a holderless and torqueless design, which reduces installation efforts.

NEWS HEADLINES

Alvotech And Dr. Reddy's Announce FDA Acceptance Of Biologic License Application For AVT03, A Proposed Biosimilar To Prolia And Xgeva

Pfizer's IXIFI Will Be Available In Canada As Of April 1, 2025

Alvotech Acquires Xbrane's R&D Operations In Sweden And Further Affirms Its Global Leadership Position In Biosimilars Development And Production